Thyrotropin in the development and management of differentiated thyroid cancer.

Endocrinol Metab Clin North Am

Department of Internal Medicine & Aged Care, Royal Brisbane & Women's Hospital, Level 3, Dr James Mayne Building, Herston, Queensland 4029, Australia; Department of Endocrinology, Royal Brisbane & Women's Hospital, Level 1, Dr James Mayne Building, Herston, Queensland 4029, Australia; Department of Population Health, QIMR Berghofer Medical Research Institute, Herston Road, Herston, Queensland 4029, Australia. Electronic address:

Published: June 2014

Thyrotropin (TSH) is the major regulator and growth factor of the thyroid. TSH may be important in the development of human thyroid cancer, with both suggestive animal models and clinical evidence, although definitive proof is still required. Applications for TSH in thyroid cancer management include TSH stimulation of radioiodine uptake, enhancement of biochemical monitoring through thyroglobulin measurement, and long-term suppression of TSH with supraphysiologic levothyroxine. This review synthesizes current knowledge of TSH in both the development and management of differentiated thyroid cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2014.02.012DOI Listing

Publication Analysis

Top Keywords

thyroid cancer
16
development management
8
management differentiated
8
differentiated thyroid
8
tsh development
8
tsh
6
thyroid
5
thyrotropin development
4
cancer
4
cancer thyrotropin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!